Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03030313 · ClinicalTrials.gov registry record · NA

Respiration Rate Monitoring in COPD Patients

A NA study, sponsored by ResMed.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT03030313 is a NA study that has completed, run by ResMed. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03030313, a NA study, has completed, sponsored by ResMed.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

Assess the feasibility of using remote respiration rate monitoring as a component of home care, how respiration rate data may be used in combination with other data to potentially improve response to symptoms, and to generate data to inform the endpoints and effect sizes of future studies.

Interventions

  • DEVICE Reassure Non-Contact Respiration Monitor

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-12-01
Est. Completion 2017-07-26
Phase NA

Sponsor

ResMed

25 total trials

What the Registry Record Tells You About NCT03030313

The ClinicalTrials.gov registry entry for NCT03030313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ResMed, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Reassure Non-Contact Respiration Monitor is the first listed.

NCT03030313 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03030313 about?

NCT03030313 is a clinical study titled "Respiration Rate Monitoring in COPD Patients". Assess the feasibility of using remote respiration rate monitoring as a component of home care, how respiration rate data may be used in combination with other data to potentially improve response to symptoms, and to generate data to inform the endpoints and effect sizes of future studies.

What is the current status of trial NCT03030313?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-12-01. Estimated completion is 2017-07-26.

What interventions are being tested in trial NCT03030313?

The interventions under investigation include: Reassure Non-Contact Respiration Monitor (DEVICE).

Who is sponsoring clinical trial NCT03030313?

This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.